Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pfizer Inc Lowers FY 2013 Guidance

Monday, 24 Jun 2013 09:09am EDT 

Pfizer Inc announced that for fiscal 2013, it expects revenue to be in the range of $50.8 to 52.8 billion (previously $55.3 to $57.3 billion) and adjusted Diluted EPS to be in the range of $2.10 to $2.20 (previously $2.14 to $2.24). According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $55.68 billion and EPS of $2.21 for fiscal 2013. 

Company Quote

-0.52 -1.42%
29 Sep 2014